市场调查报告书
商品编码
1422958
2024-2032 年 G 蛋白偶联受体市场(按产品、检测类型、应用和地区划分)G-Protein Coupled Receptors Market by Product, Assay Type, Application, and Region 2024-2032 |
2023年全球G蛋白偶联受体(GPCR)市场规模达34亿美元。展望未来, IMARC Group预计到2032年市场规模将达到57亿美元,2024年复合年增长率(CAGR)为5.69% 2032. GPCR 在药物发现中的日益采用、癌症病例数量的增加以及广泛的研发 (R&D) 活动是推动市场发展的一些关键因素。
G蛋白偶联受体(GPCR)是人类基因组编码的最大的蛋白质家族。它们是讯号传导分子,将讯号传递给细胞,并在将细胞外刺激转化为细胞内反应方面发挥关键作用。它们位于细胞膜中,负责所有生理过程。 GPCR 是细胞表面受体,其作用类似于脂质、糖、光能、胜肽和蛋白质形式的讯息收件匣。这些受体广泛用于治疗各种疾病,例如发炎性疾病、代谢失衡、心臟病、癌症和单基因疾病。因此,GPCR 也存在于多种生物体的细胞膜中,包括哺乳动物、植物、微生物和无脊椎动物。
全球药物发现中越来越多地采用 GPCR 是推动市场成长的关键因素之一。与此一致的是,由于癌症病例和心血管感染和呼吸困难等与生活方式相关的疾病数量不断增加,GPCR在新型药物开发中的广泛应用有利于市场成长。此外,GPCR 在多种生理过程中已广泛应用,因为它们位于细胞表面,并且可以被多种化学或生物製剂调节,因此可以作为另一种生长诱导因子。除此之外,将自动化和创新技术与药物开发筛选程序结合,以提高其治疗生产能力,这也为市场成长提供了动力。此外,有效药物发现方法的重大发展,例如简化受体结构和新药配方的计算方法的进步,正在推动市场成长。此外,GPCR 在肿瘤学和癌症生物学各个方面(如侵袭、迁移和血管重塑)的广泛采用,为市场成长提供了相当大的推动力。除此之外,越来越多地利用 GPCR 来解码肿瘤的转移和生长并开发有效的治疗方案,对市场成长产生了积极影响。其他因素,包括广泛的研发(R&D)活动、各种自动化改进、环磷酸腺苷(cAMP)的广泛采用以及政府在生物技术和生物製药领域实施的各种倡议预计将推动市场成长。
The global G-protein coupled receptors (GPCRs) market size reached US$ 3.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.7 Billion by 2032, exhibiting a growth rate (CAGR) of 5.69% during 2024-2032. The increasing adoption of GPCRs in drug discovery, the rising number of cancer cases, and extensive research and development (R&D) activities represent some of the key factors driving the market.
G-protein-coupled receptors (GPCRs) are the largest protein family encoded by the human genome. They are signal-transducing molecules that transmit signals to cells and play a key role in converting an extracellular stimulus into intracellular responses. They are located in the cell membrane and are responsible for all physiological processes. GPCRs are cell surface receptors that act like an inbox for messages in the form of lipids, sugars, light energy, peptides, and proteins. These receptors are widely used in the treatment of various diseases, such as inflammatory disorders, metabolic imbalances, cardiac disorders, cancer, and monogenic disorders. As a result, GPCRs are also found in the cell membranes of several organisms, including mammals, plants, microorganisms, and invertebrates.
The increasing adoption of GPCRs in drug discovery across the globe is one of the key factors driving the market growth. In line with this, the widespread utilization of GPCRs in the development of novel pharmaceuticals due to the rising number of cancer cases and lifestyle-related diseases, such as cardiovascular infections and respiratory difficulties, are favoring the market growth. Moreover, the extensive application of GPCRs in several physiological processes as they can be modulated by a wide range of chemical or biological agents due to their cell-surface location is acting as another growth-inducing factor. Apart from this, the integration of automation and innovative technologies with drug development screening procedures to improve their capabilities in therapeutic production is providing an impetus to the market growth. Furthermore, significant developments in effective drug discovery methods, such as advancements in the computational approaches to streamline receptor structure and formulation of new drugs, are propelling the market growth. Additionally, the widespread adoption of GPCRs in oncology and various aspects of cancer biology, such as invasion, migration, and vascular remolding, is providing a considerable boost to the market growth. Besides this, the increasing utilization of GPCRs for decoding metastasis and growth of tumors and developing effective lines of treatment is positively influencing the market growth. Other factors, including extensive research and development (R&D) activities, various automation improvements, the widespread adoption of cyclic Adenosine Monophosphate (cAMP), and the implementation of various government initiatives in the biotechnology and biopharmaceutical sector are anticipated to drive the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global G-protein coupled receptors (GPCRs) market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on product, assay type, and application.
Cell Lines
Detection Kits
Cell Culture Reagents
Ligands
The report has provided a detailed breakup and analysis of the G-protein coupled receptors (GPCRs) market based on the product. This includes cell lines, detection kits, cell culture reagents and ligands. According to the report, cell lines represented the largest segment.
cAMP Functional Assays
Calcium Functional Assays
B-Arrestin Functional Assays
Radioligand Binding and GTPγS Functional Assays
Internalization Assays
Trafficking Assays
Others
The report has provided a detailed breakup and analysis of the G-protein coupled receptors (GPCRs) market based on the assay type. This includes cAMP functional, calcium functional, B-Arrestin functional, radioligand binding and GTPγS functional, internalization, and trafficking assays. According to the report, cAMP functional assays represented the largest segment.
Cancer Research
CNS Research
Metabolic Research
Cardiovascular Research
Inflammation Research
Respiratory Research
Others
The report has provided a detailed breakup and analysis of the G-protein coupled receptors (GPCRs) market based on the application. This includes cancer, CNS, metabolic, cardiovascular, inflammation, respiratory research, and others. According to the report, cancer research represented the largest segment.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for G-protein coupled receptors (GPCRs). Some of the factors driving the North America G-protein coupled receptors (GPCRs) market included rising number of cancer cases, extensive research and development (R&D) activities, and various automation improvements.
The report has also provided a comprehensive analysis of the competitive landscape in the global G-protein coupled receptors (GPCRs) market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abcam plc, Becton Dickinson and Company, Enzo Biochem Inc., Eurofins DiscoverX Products LLC, HD Biosciences Co. Ltd. (WuXi AppTec), Merck KGaA, Molecular Devices LLC (Danaher Corporation), PerkinElmer Inc., Promega Corporation, Thermo Fisher Scientific Inc., etc.